Other Events ·
NexGel, Inc. held its Annual Meeting of Stockholders on July 31, 2026
NXGLWNexgel, Inc.
NexGel, Inc. held its Annual Meeting of Stockholders on July 31, 2026. Shareholders elected seven directors to the Board; Scott R. Henry was not re-elected as he resigned effective July 1, 2026. The company received shareholder approval for the issuance of shares upon conversion of convertible notes and exercise of warrants from April and May 2026 private placements under Nasdaq Listing Rule 5635(d). However, three proposals failed to receive majority support: reincorporation from Delaware to Nevada, increasing authorized common stock from 25 million to 100 million shares, and authorizing a reverse stock split with a ratio between 1-for-2 and 1-for-10. Advisory say-on-pay compensation approval and the ratification of Turner, Stone & Company as independent auditors were both approved. NexGel operates in the medical device industry, developing technologies for wound care and tissue regeneration.